South Dakota Clinical Trials

Recruiting studies in South Dakota

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT06667076Carcinoma, Non-Small-Cell LungSioux Falls, SD
• Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
  NCT06172296Ganglioneuroblastoma, NodularSioux Falls, SD
• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
  NCT03435796NeoplasmsSioux Falls, SD
• KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
  NCT04165798Carcinoma, Non-Small-Cell LungSioux Falls, SD
• Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
  NCT07527858Advanced Microsatellite Stable Colorectal CancerSioux Falls, SD
• A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
  NCT07227597Small Cell Lung Cancer Extensive StageSioux Falls, SD
• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
  NCT06541704Age-related Macular Degeneration (AMD)Rapid City, SD
• Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
  NCT07061964Muscle Invasive Bladder Urothelial CarcinomaSioux Falls, SD
• Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
  NCT05001880Peritoneal Malignant MesotheliomaSioux Falls, SD
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
  NCT06736574Heart FailureRapid City, SD
• Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
  NCT07022483Endometrial CancerSioux Falls, SD
• A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
  NCT06064097Stage II Nasopharyngeal Carcinoma AJCC v8Sioux Falls, SD

See all 226 recruiting South Dakota trials →

Popular conditions in South Dakota

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in South Dakota?

Corterve aggregates actively recruiting clinical trials with sites in South Dakota from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.

Are clinical trials in South Dakota free to join?

Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.

What kinds of clinical trials are available in South Dakota?

South Dakota research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.